Finance

Lists
Why is 301263 up 4.88%?
Dive Deeper
301263:SHE
Guangdong Taienkang Pharmaceut Co Ltd
CNÂ¥20.19
+4.88%
(+0.94) 1D
Nov 4, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301263...
Open
CNÂ¥19.24
High
CNÂ¥20.31
Low
CNÂ¥19.15
Mkt. cap
9.83B
Avg. vol.
4.55M
Volume
6.80M
Dividend
0.21%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 1, 2026
P/E ratio
361.57
52-wk high
CNÂ¥29.78
52-wk low
CNÂ¥16.88
EPS
CNÂ¥0.06
Shares outstanding
510.60M
No. of employees
1K
Open
CNÂ¥19.24
High
CNÂ¥20.31
Low
CNÂ¥19.15
Mkt. cap
9.83B
Avg. vol.
4.55M
Volume
6.80M
Dividend
0.21%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 1, 2026
P/E ratio
361.57
52-wk high
CNÂ¥29.78
52-wk low
CNÂ¥16.88
EPS
CNÂ¥0.06
Shares outstanding
510.60M
No. of employees
1K
News stories
From web sources and news partners
About Guangdong Taienkang Pharmaceut Co Ltd
CEO-
Employees1.15K
FoundedJan 22, 1999
Headquarters-
SectorPharmaceutical industry
Industry-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
149.07M
189.52M
130.76M
212.41M
Cost of goods sold
84.18M
70.35M
74.87M
76.76M
Cost of revenue
84.18M
70.35M
74.87M
76.76M
Research and development expenses
23.44M
13.59M
16.93M
14.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.31M
70.73M
84.21M
91.61M
Operating expense
83.83M
85.13M
106.92M
102.68M
Total operating expenses
168.01M
155.47M
181.78M
179.44M
Operating income
-18.94M
34.04M
-51.02M
32.97M
Other non operating income
-512.13K
-612.31K
717.14K
-10.76M
EBT including unusual items
-27.84M
30.45M
-47.35M
26.37M
EBT excluding unusual items
-22.67M
31.60M
-49.54M
26.74M
Income tax expense
-18.62M
5.53M
-18.45M
2.45M
Effective tax rate
66.87%
18.18%
38.98%
9.31%
Other operating expenses
685.26K
816.63K
1.71M
562.42K
Net income
-2.77M
28.58M
-24.86M
27.76M
Net profit margin
-1.86%
15.08%
-19.01%
13.07%
Earnings per share
-
-
-
-
Interest and investment income
3.23M
1.49M
4.10M
6.71M
Interest expense
-5.88M
-3.33M
-3.38M
-2.13M
Net interest expenses
-2.65M
-1.83M
720.71K
4.57M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.00M
49.98M
-34.32M
48.91M
Gain or loss from assets sale
-193.19K
-
78.42K
-78.42K
Upcoming events
AI content may include mistakes. Learn more
Google apps